Literature DB >> 18612247

Genetic screen for genes involved in Chk2 signaling in Drosophila.

Suk-Young Park1, Young-Han Song.   

Abstract

Chk2 is a well characterized protein kinase with key roles in the DNA damage response. Chk2 is activated by phosphorylation following DNA damage, and relays that signal to various substrate proteins to induce cell cycle arrest, DNA repair, and apoptosis. In order to identify novel components of the Chk2 signaling pathway in Drosophila, we screened 2,240 EP misexpression lines for dominant modifiers of an adult rough eye phenotype caused by Chk2 overexpression in postmitotic cells of the eye imaginal disc. The rough eye phenotype was suppressed by mutation of the ATM kinase, a well-described activator of Chk2. Twenty-five EP modifiers were identified (three enhancers and 22 suppressors), none of which correspond to previously known components of Chk2 signaling. Three EPs caused defects in G2 arrest after irradiation with incomplete penetrance when homozygous, and are likely directly involved in the response to DNA damage. Possible roles for these modifiers in the DNA damage response and Chk2 signaling are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612247

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  3 in total

Review 1.  Histone lysine demethylases in Drosophila melanogaster.

Authors:  Andreana Holowatyj; Zeng-Quan Yang; Lori A Pile
Journal:  Fly (Austin)       Date:  2015       Impact factor: 2.160

2.  A screen for E3 ubiquitination ligases that genetically interact with the adaptor protein Cindr during Drosophila eye patterning.

Authors:  Kwami F Ketosugbo; Henry L Bushnell; Ruth I Johnson
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240

3.  Nutrient Limitation Inactivates Mrc1-to-Cds1 Checkpoint Signalling in Schizosaccharomyces pombe.

Authors:  Jessica Fletcher; Liam Griffiths; Thomas Caspari
Journal:  Cells       Date:  2018-02-23       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.